SEQ is the only DLBCL MRD assay available for clinical use and covered by Medicare SEATTLE, (GLOBE NEWSWIRE) --  Adaptive ...

Q4 2024 Earnings Call Transcript March 13, 2025 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

In a recent study, PAC-MANN identified pancreatic ductal adenocarcinoma samples with 98% specificity and 73% sensitivity ...

As the PDAC convention unfolds in Toronto, drawing thousands of mining executives and enthusiasts alike, one junior miner is ...

This study identifies previously undetected PFAS in East Asian-Australian wildlife, emphasizing the TOP assay's role in ...

Jacob E. Berchuck, MD, highlights challenges in adopting liquid biopsy for PSMA expression and its potential to revolutionize precision medicine in prostate cancer.

Arizona Metals' shares popped Monday, eating into recent weakness after the company issued assay results from exploration work on its Kay project in Arizona. In morning trading, the shares were 5.4% ...

A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...

Patients with irritable bowel syndrome are more likely to benefit from a diet that eliminates any food triggering an IgG ...

A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.

The Total Oxidizable Precursor assay has identified higher levels of PFAS in birds than previously recorded. A research team from the Norwegian University of Science and Technology (Trondheim, Norway) ...